Nordic Bioscience has more than 30 years’ experience in biomarker development and integrating these biomarkers into clinical trials with extensive scientific expertise in the fields of cardiovascular, fibrosis, immunoscience and oncology.

Using our unique biomarker technology, we identify predictive and prognostic biomarkers which are used to enrich clinical trials and may reduce trial length and size required to determine therapeutic efficacy.

With over 550 publications in leading journals, we pride ourselves with our highly scientific approach and mindset.

Welcome to the Biomarker Powerhouse!